Salarius Pharmaceuticals Inc (SLRX)

Salarius Pharmaceuticals Inc Azioni (SLRX) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	-	-	-	-	-
Operating Expenses	82.51% 1.7716	0.9707	2.5322	3.9714	5.4207
Operating Income/Loss	82.51% -1.7716	-0.9707	-2.5322	-3.9714	-5.4207
Income/Loss From Continuing Operations Before Tax	94.52% -1.7153	-0.8818	-2.4428	-3.8773	-5.3408
Income/Loss From Continuing Operations After Tax	94.52% -1.7153	-0.8818	-2.4428	-3.8773	-5.3408
Net Income/Loss	94.52% -1.7153	-0.8818	-2.4428	-3.8773	-5.3408
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,747% 4.1946	0.2271	3.754	2.7091	2.392
Diluted Average Shares	1,747% 4.1946	0.2271	3.754	2.7091	2.392
Basic Earnings Per Share	-0.41	-	-0.65	-1.43	-2.23
Diluted Earnings Per Share	-0.41	-	-0.65	-1.43	-2.23
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-